SCHEMBL7045327

SCHEMBL7045327

CCC(F)C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28487090 0.97
SCHEMBL18528137 0.78
SCHEMBL10651099 0.75
SCHEMBL11306186 0.74
SCHEMBL8024695 0.73
SCHEMBL310632 0.73
SCHEMBL809779 0.73
SCHEMBL134555 0.73
SCHEMBL1031678 0.73
SCHEMBL1030200 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4058445-B1 GLP-1 RECEPTOR AGONIST AND USE THEREOF ILDONG PHARMACEUTICAL CO LTD (KR) 2025-03-26 EP disclosed
CN-118515865-A Nylon copolymer and preparation method and application thereof 中国石油化工股份有限公司 2024-08-20 CN disclosed
US-11932618-B2 GLP-1 receptor agonist and use thereof ILDONG PHARMACEUTICAL CO., LTD. (KR) 2024-03-19 US disclosed
CN-114728939-B GLP-1 receptor agonists and uses thereof 日东制药株式会社 2023-12-08 CN disclosed
US-20230212140-A1 GLP-1 RECEPTOR AGONIST AND USE THEREOF ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-07-06 US disclosed
US-11643403-B2 GLP-1 receptor agonist and use thereof ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-05-09 US disclosed
CN-116041669-A Epoxy resin monomer and preparation method and application thereof 中国建筑材料科学研究总院有限公司 2023-05-02 CN disclosed
US-20230013143-A1 GLP-1 RECEPTOR AGONIST AND USE THEREOF ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-01-19 US disclosed
EP-4058445-A1 GLP-1 RECEPTOR AGONIST AND USE THEREOF Ildong Pharmaceutical Co., Ltd. (KR) 2022-09-21 EP disclosed
CN-114728939-A GLP-1 receptor agonists and uses thereof 日东制药株式会社 2022-07-08 CN disclosed
EP-3109230-A1 CLASS OF CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN PREPARATION OF PRODRUGS Li, Qingeng (CN) 2016-12-28 EP disclosed
EP-3109229-A1 WATER-SOLUBLE PROPOFOL DERIVATIVES AND USES THEREOF Jiangsu Nhwaluokang Pharmceutical Research and Development Co. Ltd. (CN) 2016-12-28 EP disclosed
CN-102020697-B Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication F. HOFFMANN-LA ROCHE LTD. (CH) 2014-10-29 CN disclosed
CN-103145715-A Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication HOFFMANN LA ROCHE 2013-06-12 CN disclosed
CN-102020697-A Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication INTERMUNE INC 2011-04-20 CN disclosed
CN-1938311-A Macrocyclic compounds as inhibitors of viral replication INTERMUNE INC (US) 2007-03-28 CN disclosed
CN-1229382-C Semi-synthetic process and intermediates thereof PHARMA MAR SA (ES) 2005-11-30 CN disclosed
EP-1392779-A1 FLUORINATED-PHOTOINITIATORS IN DUAL CURE RESINS Ciba SC Holding AG (CH) 2004-03-03 EP disclosed
CN-1360588-A Hemisynthetic method and intermediate thereof PHARMA MAR SA (ES) 2002-07-24 CN disclosed
WO-2002040602-A1 FLUORINATED-PHOTOINITIATORS IN DUAL CURE RESINS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-05-23 WO disclosed